Provel S.r.l. has been acquired by 3D Systems Corporation
3D Systems Corporation has announced the acquisition of Provel S.r.l., an Italian provider of rapid prototyping, tooling and manufacturing services, as part of the company’s continued expansion of its activities in Europe, for an undisclosed consideration.
Provel' management will remain with the company and play an important role in 3D Systems Corporation's development in Italy and in Europe.
3D Systems Corporation is a listed USA company and a leading provider of 3D printing, rapid prototyping and manufacturing systems, and parts solutions. Its expertly integrated solutions are used for design communication and prototyping as well as for production of functional end-use parts.
Oaklins' team in Italy advised the vendors throughout this transaction.


Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more